Phase II trial of amsacrine (AMSA) in urinary bladder cancer. | Cancer Treat Rep;67(4): 391-2, 1983 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Subject descriptor lookup Advanced Search EVID@Easy

Phase II trial of amsacrine (AMSA) in urinary bladder cancer.

Natale, R B; Yagoda, A; Blumenreich, M S; Watson, R C.

Cancer Treat Rep ; 67(4): 391-2, 1983 Apr.

Article in En | MEDLINE | ID: mdl-6687836

Subject(s)

Aminoacridines/therapeutic use; Antineoplastic Agents/therapeutic use; Urinary Bladder Neoplasms/drug therapy; Adult; Aged; Aminoacridines/adverse effects; Amsacrine; Antineoplastic Agents/adverse effects; Drug Evaluation; Female; Humans; Leukopenia/chemically induced; Male; Middle Aged; Neoplasm Metastasis

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Aminoacridines / Antineoplastic Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Treat Rep Year: 1983 Document type: Article Country of publication: United States

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Aminoacridines / Antineoplastic Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Cancer Treat Rep Year: 1983 Document type: Article Country of publication: United States